After one-week and two-week exposure to the drugs, serum levels of ALT, AST, BUN, and Cr in regular-dose MPS-NSSLs-SPANb (MPS 1 mg/kg) and low-dose MPS-NSSLs-SPANb (MPS 0.5 mg/kg)+AE-IPF groups were similar as those in the normal control group (Table S4). The gene discussed is GPT; the disease is idiopathic pulmonary fibrosis.